Hepatic Impairment Withdrawn Phase 1 Trials for Lanabecestat (DB14814)

Also known as: Liver impairment / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Liver Diseases / Unspecified disorder of liver

IndicationStatusPhase
DBCOND0031585 (Hepatic Impairment)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03499041A Study of LY3314814 in Participants With Liver ImpairmentBasic Science